Related references
Note: Only part of the references are listed.FDA approves 100th monoclonal antibody product
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Physicochemical Stability of Monoclonal Antibodies: A Review
Yoann Le Basle et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
The cost of cancer in Europe 2018
Thomas Hofmarcher et al.
EUROPEAN JOURNAL OF CANCER (2020)
Effect of UVC Irradiation on the Oxidation of Histidine in Monoclonal Antibodies
Yuya Miyahara et al.
SCIENTIFIC REPORTS (2020)
Forced Degradation of Monoclonal Antibodies After Compounding: Impact on Routine Hospital Quality Control
Emmanuel Jaccoulet et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Rapid global characterization of immunoglobulin G1 following oxidative stress
Yao Chen et al.
MABS (2019)
Stability of infliximab solutions in different temperature and dilution conditions
Nicolas Tokhadze et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Method for Quantifying Oxidized Methionines and Application to HIV-1 Env
Joshua T. Shipman et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2018)
Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal Antibodies
Qingrong Yan et al.
MABS (2018)
Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at various temperatures
Victoire Vieillard et al.
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2018)
Cluster-based comparison of the peptide mass fingerprint obtained by MALDI-TOF mass spectrometry. A case study: long-term stability of rituximab
Pablo J. Villacorta et al.
ANALYST (2015)
Rapid Level-3 Characterization of Therapeutic Antibodies by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry
Clarence Lew et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2015)
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer
Nadia Harbeck et al.
BREAST CARE (2013)
Cysteine Racemization on IgG Heavy and Light Chains
Qingchun Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration
Zephania W. Kwong Glover et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Long-term stability of diluted solutions of the monoclonal antibody rituximab
Muriel Paul et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Guidelines for the practical stability studies of anticancer drugs: a European consensus conference
C. Bardin et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2012)
Choosing the right cell line for breast cancer research
Deborah L. Holliday et al.
BREAST CANCER RESEARCH (2011)
Effect of Collision Energy Optimization on the Measurement of Peptides by Selected Reaction Monitoring (SRM) Mass Spectrometry
Brendan MacLean et al.
ANALYTICAL CHEMISTRY (2010)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
Ligand-Specific c-Fos Expression Emerges from the Spatiotemporal Control of ErbB Network Dynamics
Takashi Nakakuki et al.
CELL (2010)
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
Jeffrey S. Ross et al.
ONCOLOGIST (2009)
Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody
Sandipan Sinha et al.
PROTEIN SCIENCE (2009)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature
Hongcheng Liu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes
B Cen et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
The ErbB signaling network: receptor heterodimerization in development and cancer
MA Olayioye et al.
EMBO JOURNAL (2000)